Unilife Corporation Included in S&P Australian 300 Index
LEWISBERRY, Pa., Sept. 8 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS, ASX: UNS), today announced that it was included in the Standard & Poor's S&P/ASX 300® Index as of Thursday, September 2, 2010.
The S&P/ASX 300® Index is comprised principally of the 300 largest and most liquid stocks listed and traded on the Australian Stock Exchange. Inclusion in the S&P/ASX 300® Index is based on certain criteria regarding listing, size and liquidity and is rebalanced every six months.
"Standard & Poor's Index Services is the leading provider of equity indices in Australia, as such, being included in the S&P/ASX 300® Index is an important achievement for Unilife and will help increase our Company's visibility among investors in the Australian equity market," stated Alan Shortall, CEO of Unilife Corporation. "Membership in this widely followed index comes in addition to being included in approximately 25 indices in the U.S., including the Russell 2000, Russell Microcap and Russell Global indexes."
The S&P/ASX 300® provides up to an additional 100 small cap stocks to the S&P/ASX 200. This index is designed to address investment managers' needs to benchmark against a portfolio characterized by sufficient size and liquidity. S&P/ASX 300 is a component of the Australian indices that could be used as building blocks for portfolio construction.
Index performance data for the S&P/ASX 300® is available at http://www.standardandpoors.com/indices/sp-asx-300/en/us/?indexId=spausta300audff--p-au----
About Standard & Poor's
Standard & Poor's, a subsidiary of The McGraw-Hill Companies (NYSE: MHP), is the world's foremost provider of independent credit ratings, indices, risk evaluation, investment research and data. With offices in 23 countries and markets, Standard & Poor's is an essential part of the world's financial infrastructure and has played a leading role for 150 years in providing investors with the independent benchmarks they need to feel more confident about their investment and financial decisions. For more information, visit http://www.standardandpoors.com
About Unilife Corporation
Unilife Corporation is a U.S.-based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. Primary target customers for Unilife products include pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities and patients who self-administer prescription medication. These patent-protected syringes incorporate automatic and fully-integrated safety features which are designed to protect those at risk of needlestick injuries and unsafe injection practices. Unilife is ISO 13485 certified and has FDA-registered medical device manufacturing facilities in Pennsylvania.
This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our registration statement on Form 10 and those described from time to time in our periodic reports which we file with the Securities and Exchange Commission.
General: UNIS-G
Investor Contacts (US): |
Investor Contacts (Australia) |
||
Todd Fromer / Garth Russell |
Stuart Fine |
Jeff Carter |
|
KCSA Strategic Communications |
Carpe DM Inc |
Unilife Corporation |
|
Phone + 1 212-682-6300 |
Phone + 1 908 469 1788 |
Phone + 61 2 8346 6500 |
|
SOURCE Unilife Corporation
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article